Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01350 (
gastrin
)
9,683
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The peptide hormone
gastrin
is known to play a role in differentiation, growth and apoptosis of cells in the gastric mucosa. In this study we demonstrate that
gastrin
induces Nuclear Receptor 4A2 (NR4A2) expression in the adenocarcinoma cell lines AR42J and AGS-GR, which both possess the
gastrin
/CCK2 receptor. In vivo, NR4A2 is strongly expressed in the
gastrin
responsive neuroendocrine ECL cells in normal mucosa, whereas gastric adenocarcinoma tissue reveals a more diffuse and variable expression in tumor cells. We show that NR4A2 is a primary early transient
gastrin
induced gene in adenocarcinoma cell lines, and that NR4A2 expression is negatively regulated by inducible cAMP early repressor (ICER) and
zinc finger protein 36
, C3H1 type-like 1 (Zfp36l1), suggesting that these
gastrin
regulated proteins exert a negative feedback control of NR4A2 activated responses. FRAP analyses indicate that
gastrin
also modifies the nucleus-cytosol shuttling of NR4A2, with more NR4A2 localized to cytoplasm upon
gastrin
treatment. Knock-down experiments with siRNA targeting NR4A2 increase migration of
gastrin
treated adenocarcinoma AGS-GR cells, while ectopically expressed NR4A2 increases apoptosis and hampers
gastrin
induced invasion, indicating a tumor suppressor function of NR4A2. Collectively, our results uncover a role of NR4A2 in gastric adenocarcinoma cells, and suggest that both the level and the localization of NR4A2 protein are of importance regarding the cellular responses of these cells.
...
PMID:NR4A2 is regulated by gastrin and influences cellular responses of gastric adenocarcinoma cells. 2408 17